GlassScriptPhysician profile
Kenneth Cerreta
NPI 1093004160
$6,515.26
in general payments reported to CMS, 2019-2025
37 companies · $1,575 in 2025
The $1,575 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $911 · 2020: $505 · 2021: $120 · 2022: $517 · 2023: $875 · 2024: $2,013 · 2025: $1,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,801 · Consulting Fee: $600 · Education: $61.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,800.94 |
| Consulting Fee | $600.00 |
| Education | $61.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,076.72 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $821.78 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $811.81 | 2019-2025 | Airsupra, Tezspire, Fasenra |
| Insmed, INC. | $573.35 | 2020-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $347.75 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Takeda Pharmaceuticals U.S.A., INC. | $240.26 | 2022-2025 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.79 | 2019-2024 | Ofev |
| Amgen INC. | $210.55 | 2021-2025 | Tezspire, Tavneos |
| Inari Medical, INC. | $190.84 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Regeneron Healthcare Solutions, INC. | $187.98 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $181.19 | 2023-2025 | Tyvaso, Orenitram, Remodulin |
| Harmony Biosciences LLC | $175.46 | 2020-2025 | |
| Abbvie INC. | $168.44 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $133.05 | 2024-2025 | Winrevair |
| Electromed, INC. | $126.99 | 2019-2025 | Smartvest |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2022 | |
| Grifols USA, LLC | $115.26 | 2024-2025 | Prolastin-C Liquid |
| Shionogi INC | $99.09 | 2023-2025 | Fetroja |
| Vapotherm INC | $84.44 | 2022-2023 | Vapotherm |
| Allergan, INC. | $80.35 | 2019-2020 | |
| Verona Pharma, INC. | $80.31 | 2025 | Ohtuvayre |
| Inspire Medical Systems, INC. | $76.63 | 2023-2024 | Inspire |
| Mylan Specialty L.P. | $60.93 | 2019-2020 | |
| Genzyme Corporation | $56.72 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $47.38 | 2019-2025 | |
| Inogen, INC. | $34.95 | 2022-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $29.97 | 2024 | Lumryz |
| Janssen Pharmaceuticals, INC | $29.39 | 2019-2021 | |
| Pfizer INC. | $25.41 | 2019 | |
| Philips North America LLC | $18.45 | 2020 | |
| Genentech USA, INC. | $15.80 | 2019 | |
| Csl Behring | $15.78 | 2019 | |
| Shire North American Group INC | $13.40 | 2019 | |
| Advanced Respiratory, INC | $13.05 | 2019 | |
| Circassia INC. | $12.67 | 2019 | |
| Jazz Pharmaceuticals INC. | $11.91 | 2019 | |
| Nabriva Therapeutics, Plc | $11.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Cerreta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.